RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 91 filers reported holding RHYTHM PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,527,321 | +9.4% | 110,243 | -21.3% | 0.00% | – |
| Q2 2023 | $2,310,546 | -64.0% | 140,118 | -61.0% | 0.00% | -100.0% |
| Q1 2023 | $6,416,442 | -17.2% | 359,666 | +35.1% | 0.00% | 0.0% |
| Q4 2022 | $7,750,375 | +44.8% | 266,153 | +21.9% | 0.00% | 0.0% |
| Q3 2022 | $5,351,000 | +2536.0% | 218,409 | +344.7% | 0.00% | – |
| Q2 2022 | $203,000 | -55.6% | 49,112 | +24.0% | 0.00% | – |
| Q1 2022 | $457,000 | -62.6% | 39,615 | -67.7% | 0.00% | – |
| Q4 2021 | $1,223,000 | -54.2% | 122,635 | -40.0% | 0.00% | – |
| Q3 2021 | $2,670,000 | +13.9% | 204,463 | +70.8% | 0.00% | – |
| Q2 2021 | $2,344,000 | +3.5% | 119,678 | +12.4% | 0.00% | – |
| Q1 2021 | $2,264,000 | -15.5% | 106,442 | +18.1% | 0.00% | – |
| Q4 2020 | $2,680,000 | -55.6% | 90,159 | -67.6% | 0.00% | -100.0% |
| Q3 2020 | $6,032,000 | +5.6% | 278,380 | +8.7% | 0.00% | 0.0% |
| Q2 2020 | $5,712,000 | +706.8% | 256,158 | +450.8% | 0.00% | – |
| Q1 2020 | $708,000 | -38.4% | 46,509 | -7.1% | 0.00% | – |
| Q4 2019 | $1,149,000 | +50.2% | 50,060 | +41.2% | 0.00% | – |
| Q3 2019 | $765,000 | +30.5% | 35,456 | +33.1% | 0.00% | – |
| Q2 2019 | $586,000 | +8.3% | 26,633 | +34.8% | 0.00% | – |
| Q1 2019 | $541,000 | -23.2% | 19,762 | -24.6% | 0.00% | – |
| Q4 2018 | $704,000 | +98.9% | 26,196 | +116.3% | 0.00% | – |
| Q3 2018 | $354,000 | +81.5% | 12,111 | +93.7% | 0.00% | – |
| Q2 2018 | $195,000 | +230.5% | 6,251 | +110.5% | 0.00% | – |
| Q1 2018 | $59,000 | -44.9% | 2,969 | -19.8% | 0.00% | – |
| Q4 2017 | $107,000 | – | 3,702 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,075,000 | $47,569,375 | 5.56% |
| NEA Management Company, LLC | 2,909,956 | $66,710,741 | 5.15% |
| Opaleye Management Inc. | 653,000 | $14,970,025 | 4.87% |
| Frazier Life Sciences Management, L.P. | 2,371,304 | $54,362,144 | 3.61% |
| VR Adviser, LLC | 1,090,000 | $24,988,250 | 2.63% |
| RA Capital Management | 5,676,067 | $130,123,836 | 2.56% |
| Samsara BioCapital, LLC | 345,293 | $7,915,842 | 2.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 260,537 | $5,972,811 | 1.81% |
| Logos Global Management LP | 400,000 | $9,170,000 | 1.22% |
| Cormorant Asset Management, LP | 850,000 | $19,486,250 | 1.14% |